Research shows the Affordable Care Act helps farmers get better health care and avoid emergency rooms.

Published Date: 17 Feb 2023

More than 2.5 million agricultural workers help maintain America's food supply. They play an important role in the economy, but their work is difficult and often dangerous.

Read Full News

Todays Updates


Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again Noah Stansfield


Ultragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.

This Week on NeurologyLive® — February 9, 2026 Isabella Ciccone, MPH


Here's some of what is coming soon to NeurologyLive® this week.

AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP Marco Meglio


AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.

International Epilepsy Day 2026: Highlighting Gaps in Pediatric Care, Stigma, and Education Charuta Joshi, MD, Isabella Ciccone, MPH


Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.

Regenxbio's MPS II Gene Therapy RGX-121 Hit With CRL Noah Stansfield


The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.

Discussing Billing Challenges in Dermatology, With Daniel Siegel, MD Daniel M. Siegel, MD


In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis


New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

Todays Updates


Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again Noah Stansfield


Ultragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.

This Week on NeurologyLive® — February 9, 2026 Isabella Ciccone, MPH


Here's some of what is coming soon to NeurologyLive® this week.

AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP Marco Meglio


AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.

International Epilepsy Day 2026: Highlighting Gaps in Pediatric Care, Stigma, and Education Charuta Joshi, MD, Isabella Ciccone, MPH


Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.

Regenxbio's MPS II Gene Therapy RGX-121 Hit With CRL Noah Stansfield


The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.

Discussing Billing Challenges in Dermatology, With Daniel Siegel, MD Daniel M. Siegel, MD


In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis


New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Certain surgical gestures during prostate removal linked to better sexual function recovery

2.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

3.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

4.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

5.

Elder Abuse: Red Flags to Look Out For While Receiving Care.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot